» Articles » PMID: 37710286

Function and Mechanism of MCM8 in the Development and Progression of Colorectal Cancer

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2023 Sep 14
PMID 37710286
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) has become a global health problem which has almost highest morbidity and mortality in all types of cancers. This study aimed to uncover the biological functions and underlying mechanism of MCM8 in the development and progression of CRC. The expression level of MCM8 was found to be upregulated in CRC tissues and significantly associated with tumor grade and patients' survival. Knocking down MCM8 expression in CRC cells could restrain cell growth and cell motility while promoting cell apoptosis in vitro, as well as inhibit tumor growth in xenograft mice model. Based on the RNA screening performing on CRC cells with or without MCM8 knockdown and the following IPA analysis, CHSY1 was identified as a potential target of MCM8 in CRC, whose expression was also found to be higher in tumor tissues than in normal tissues. Moreover, it was demonstrated that MCM8 may regulate the expression of CHSY1 through affecting its NEDD4-mediated ubiquitination, both of which synergistically execute tumor promotion effects on CRC. In conclusion, the outcomes of our study showed the first evidence that MCM8 act as a tumor promotor in CRC, and may be a promising therapeutic target of CRC treatment.

Citing Articles

Expression patterns of MCM8 in lung adenocarcinoma and its correlation with key biological processes.

Liu X, Xie J, Wu R, Xiao G, Zhang Y, Pei Z Eur J Med Res. 2025; 30(1):149.

PMID: 40033404 PMC: 11874120. DOI: 10.1186/s40001-025-02407-8.


MCM8 promotes gastric cancer progression through RPS15A and predicts poor prognosis.

Ding L, Sun M, Sun Y, Li J, Zhang Z, Dang S Cancer Med. 2024; 13(13):e7424.

PMID: 38988047 PMC: 11236911. DOI: 10.1002/cam4.7424.


NEDD4 and NEDD4L: Ubiquitin Ligases Closely Related to Digestive Diseases.

Xu J, Jiang W, Hu T, Long Y, Shen Y Biomolecules. 2024; 14(5).

PMID: 38785984 PMC: 11117611. DOI: 10.3390/biom14050577.

References
1.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

2.
Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

3.
Roncucci L, Mariani F . Prevention of colorectal cancer: How many tools do we have in our basket?. Eur J Intern Med. 2015; 26(10):752-6. DOI: 10.1016/j.ejim.2015.08.019. View

4.
Lech G, Slotwinski R, Slodkowski M, Krasnodebski I . Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances. World J Gastroenterol. 2016; 22(5):1745-55. PMC: 4724606. DOI: 10.3748/wjg.v22.i5.1745. View

5.
De Rosa M, Pace U, Rega D, Costabile V, Duraturo F, Izzo P . Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 2015; 34(3):1087-96. PMC: 4530899. DOI: 10.3892/or.2015.4108. View